Please assess the completion status of the following clinical trial:

Trial Title: Efficiency of Bumetanide in Autistic Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children from 3 to 10 years old, answering the diagnosis of typical autism according to the diagnostic criteria of autism of the classification of the WHO ( CIM-10) and the parents of which gave a free, enlightened and written consent.~Exclusion Criteria:~* Patients epileptic autistics treated by anticomitiaux or having hurts of the central nervous system~* Patients autistics receiving a psychotropic treatment~* Patients presenting disorders electrolytes~* Patients presenting a hypersensibility known about sulpha drugs~* Presenting patients against indications relative to the treatment by bumetanide~* Patients already treated by diuretics~* Patients presenting a hepatic or renal incapacity~* Patients presenting an elongation of the QT to the electrocardiogram.~* Patients autistics of CARS sore is lower than 30.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- Bumetanide (Type: EXPERIMENTAL): None
- Control (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).